AVEO Oncology
AVEO
#7155
Rank
โ‚ฌ0.44 B
Marketcap
12,70ย โ‚ฌ
Share price
0.00%
Change (1 day)
134.90%
Change (1 year)

Earnings for AVEO Oncology (AVEO)

Earnings in 2022 (TTM): -โ‚ฌ26.9 Million

According to AVEO Oncology 's latest financial reports the company's current earnings are โ‚ฌ94.31 Million. In 2021 the company made an earning of -โ‚ฌ45.16 Million a decrease over its 2020 earnings that were of -โ‚ฌ30.13 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AVEO Oncology from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -โ‚ฌ26.9 Million-40.44%
2021 -โ‚ฌ45.16 Million49.9%
2020 -โ‚ฌ30.13 Million-479.04%
2019 โ‚ฌ7.94 M-276.17%
2018 -โ‚ฌ4.52 Million-91.79%
2017 -โ‚ฌ54.97 Million142.38%
2016 -โ‚ฌ22.68 Million78.51%
2015 -โ‚ฌ12.71 Million-71.55%
2014 -โ‚ฌ44.65 Million-50.72%
2013 -โ‚ฌ90.62 Million-4.88%
2012 -โ‚ฌ95.26 Million-426.29%
2011 โ‚ฌ29.19 M-159.85%
2010 -โ‚ฌ48.79 Million35.33%
2009 -โ‚ฌ36.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
โ‚ฌ19.05 B-77,594.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ6.97 B-28,489.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ1.61 B-6,656.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚ฌ4.35 B-17,817.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ6.80 B-27,762.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-โ‚ฌ1.92 Million-92.22%๐Ÿ‡บ๐Ÿ‡ธ USA